Trinity Biotech Plc Stock In The News

TRIB Stock  USD 0.64  0.03  4.48%   
Our overall analysis of Trinity Biotech's news coverage and content from conventional and social sources shows investors' bearish mood towards Trinity Biotech plc. The specific impact of Trinity Biotech news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Trinity Biotech's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Trinity Biotech headlines in addition to utilizing other, more conventional financial analysis modules. Check out Trinity Biotech Backtesting and Trinity Biotech Hype Analysis.

Trinity Biotech Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Trinity Biotech Receives Non-Compliance ...
https://www.globenewswire.com/news-release/2025/03/14/3043182/8624/en/Trinity-Biotech-Receives-Non-Compliance-Notice-Regarding-Nasdaq-Global-Select-Requirement-for-Minimum-Market-Value-of-Publicly-Held-Shares-and-Nasdaq-Minimum-Bid-Price-Requirement.html
 Bullish
Macroaxis News: globenewswire.com
Trinity Biotech Further Strengthens Focu...
https://www.globenewswire.com/news-release/2025/03/13/3042085/8624/en/Trinity-Biotech-Further-Strengthens-Focus-on-Continuous-Glucose-Monitoring-Appoints-Barclays-to-Advise-on-Ongoing-Strategic-Realignment-Process.html
 Bullish
Macroaxis News: globenewswire.com
Trinity Biotech Announces Additional Fun...
https://www.globenewswire.com/news-release/2025/02/28/3034727/8624/en/Trinity-Biotech-Announces-Additional-Funding-To-Support-Transformation-Plan-Continued-Development-of-the-Company-s-Continuous-Glucose-Monitoring-Technology.html
 Bullish
Macroaxis News: globenewswire.com
Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
https://www.globenewswire.com/news-release/2025/02/06/3021954/8624/en/Trinity-Biotech-Reports-Landmark-First-Day-Accuracy-Gains-in-CGM-Pre-Pivotal-Trial.html
 Bullish
Macroaxis News: globenewswire.com
Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology
https://www.globenewswire.com/news-release/2025/01/28/3016274/8624/en/Trinity-Biotech-Announces-Breakthrough-Results-From-Pre-Pivotal-Trial-of-Disruptive-Continuous-Glucose-Monitoring-CGM-Technology.html
 Bullish
Yahoo News
Why Is Clinical Diagnostics Focused Trinity Biotech Stock Trading Higher On Tuesday?
https://finance.yahoo.com/news/why-clinical-diagnostics-focused-trinity-125541512.html
 Bullish
Yahoo News
Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now
https://finance.yahoo.com/news/presenting-emerging-growth-conference-68-120000217.html
 Bullish
Macroaxis News: globenewswire.com
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares
https://www.globenewswire.com/news-release/2023/11/28/2787363/8624/en/Trinity-Biotech-Receives-Non-Compliance-Notice-Regarding-Nasdaq-Global-Select-Requirement-for-Minimum-Market-Value-of-Publicly-Held-Shares.html
 Neutral
Macroaxis News: globenewswire.com
Trinity Biotech Welcomes The Decision Of...
https://www.globenewswire.com/news-release/2023/10/10/2757462/8624/en/Trinity-Biotech-Welcomes-The-Decision-Of-The-High-Court-Of-Kenya-To-Strike-Out-The-Applications-To-Prevent-the-Procurement-of-TrinScreen-HIV-By-The-Kenyan-Ministry-of-Health.html
 Neutral
Macroaxis News: globenewswire.com
Trinity Biotech Announces Q2 2023 Financial Results
https://www.globenewswire.com/news-release/2023/10/03/2753762/8624/en/Trinity-Biotech-Announces-Q2-2023-Financial-Results.html
 Bullish

Trinity Biotech plc Past News Timeline

From Mar 29 to Dec 28Use up and down arrows to move selectionTo Mar 29Use up and down arrows to move upper selectionFrom Dec 28Use up and down arrows to move lower selectionUse TAB select grip buttons or up and down arrows to change selection100%
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Trinity and other traded companies coverage with news coverage. We help investors stay connected with Trinity headlines for the 29th of March to make an informed investment decision based on correlating the impacts of news items on Trinity Stock performance. Please note that trading solely based on the Trinity Biotech plc hype is not for everyone as timely availability and quick action are needed to avoid losses.
Trinity Biotech's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Trinity Biotech plc investors visualize upcoming and past events in order to time the market based on Trinity Biotech plc noise-free hype analysis.
Trinity Biotech stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Trinity earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Trinity Biotech that are available to investors today. That information is available publicly through Trinity media outlets and privately through word of mouth or via Trinity internal channels. However, regardless of the origin, that massive amount of Trinity data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Trinity Biotech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Trinity Biotech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Trinity Biotech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Trinity Biotech alpha.

Trinity Largest EPS Surprises

Earnings surprises can significantly impact Trinity Biotech's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2018-10-23
2018-09-300.060.05-0.0116 
2018-07-19
2018-06-300.060.070.0116 
2018-03-07
2017-12-310.070.080.0114 
2017-10-26
2017-09-300.070.06-0.0114 
2017-07-20
2017-06-300.060.070.0116 
2008-07-22
2008-06-300.080.07-0.0112 
View All Earnings Estimates

Trinity Biotech Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Trinity Biotech plc Stock. The global stock market is bearish. About 68% of major world exchanges and indexes are down. See today's market update for more information.
news
28th of March 2025
Super League Leigh Leopards 14-40 Wakefield Trinity
at bbc.co.uk 
news
25th of March 2025
Trump cuts hit struggling food banks, risking hunger for low-income Americans
at aol.com 
Yahoo News
19th of March 2025
Adsposure and Trinity Metro Expand Partnership with 75 New Bus Shelters
at finance.yahoo.com 
news
18th of March 2025
Trinity Rodman, Ben Shelton hard launch relationship with intimate photo
at nypost.com 
prnewswire News
17th of March 2025
DATA BREACH ALERT Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Trinity Petrol...
at prnewswire.com 
Yahoo News
13th of March 2025
Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring Appoints Barcla...
at finance.yahoo.com 
Gurufocus Stories at Macroaxis
12th of March 2025
Trinity Capital Inc. Expands Institutional Fundraising Efforts with Appointment of Zach Ta...
at gurufocus.com 
news
10th of March 2025
Ne Zha 2 Sold To Trinity CineAsia For 37 Territories In UK Europe
at deadline.com 
Yahoo News
28th of February 2025
Trinity Biotech Announces Additional Funding To Support Transformation Plan Continued Deve...
at finance.yahoo.com 
news
19th of February 2025
Curfews in Manchester extended
at jamaica-gleaner.com 
news
12th of February 2025
Houston Chron Texas judge resigns after being accused of texting tips to prosecutors
at washingtonexaminer.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Trinity Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Trinity Biotech's short interest history, or implied volatility extrapolated from Trinity Biotech options trading.
When determining whether Trinity Biotech plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Trinity Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Trinity Biotech Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Trinity Biotech Plc Stock:
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trinity Biotech. If investors know Trinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trinity Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Earnings Share
(2.25)
Revenue Per Share
6.497
Quarterly Revenue Growth
0.032
Return On Assets
(0.08)
The market value of Trinity Biotech plc is measured differently than its book value, which is the value of Trinity that is recorded on the company's balance sheet. Investors also form their own opinion of Trinity Biotech's value that differs from its market value or its book value, called intrinsic value, which is Trinity Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trinity Biotech's market value can be influenced by many factors that don't directly affect Trinity Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trinity Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Trinity Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trinity Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Trending Assets

XGN
Exagen Inc
3.84  -0.4  -9.43 
NOTV
Inotiv Inc
2.35  0.08  3.52 
GTH
Genetron Holdings
0.00  0.00  0.00 
OLK
Olink Holding AB
0.00  0.00  0.00 
News Freq…Investor S…100%